Barclays
CDMO

Barclays’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History

Barclays’s Portfolio CDMO Stock Details CDMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-10,357
Closed -$94K – 7652
2013
Q2 		$94K Buy
+10,357
New +$109K ﹤0.01% 5840

Other funds holding CDMO

TCWM
Total Clarity Wealth Management St. Charles, Illinois $515M AUM 27.37% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Barclays's CDMO Position: Q1 2025 in Review

Barclays sold out of Avid Bioservices, Inc. Common Stock (CDMO) in Q1 2025, closing a stake of 152,756 shares — an estimated $1.89M sold.

Barclays first reported a position in CDMO in Q2 2013 and held it in 38 quarters. The position peaked at $2.6M in Q4 2022. 2 funds tracked by Wall St. Rank hold CDMO as of Q1 2025.

  • Barclays reported no remaining Avid Bioservices, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
  • Barclays sold 152,756 Avid Bioservices, Inc. Common Stock shares in Q1 2025, an estimated $1.89M.
  • Barclays first reported a position in Avid Bioservices, Inc. Common Stock in Q2 2013 and held it in 38 quarters.
  • Barclays's Avid Bioservices, Inc. Common Stock position peaked at $2.6M in Q4 2022.
  • 2 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q1 2025.

Based on Barclays's 13F filing for Q1 2025, filed 15 May 2025.